E
Emily Henkle
Researcher at Kaiser Permanente
Publications - 32
Citations - 3514
Emily Henkle is an academic researcher from Kaiser Permanente. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 15, co-authored 20 publications receiving 3263 citations. Previous affiliations of Emily Henkle include Henry Ford Health System & Johns Hopkins University.
Papers
More filters
Journal ArticleDOI
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates
Katherine L. O'Brien,Lara J. Wolfson,James P. Watt,Emily Henkle,Maria Deloria-Knoll,Natalie McCall,Ellen Lee,Kim Mulholland,Orin S. Levine,Thomas Cherian +9 more
TL;DR: The burden of pneumococcal pneumonia is measured by applying the proportion of pneumonia cases caused by S pneumoniae derived from efficacy estimates from vaccine trials to WHO country-specific estimates of all-cause pneumonia cases and deaths, using disease incidence and case-fatality data from a systematic literature review.
Journal ArticleDOI
Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates.
James P. Watt,Lara J. Wolfson,Katherine L. O'Brien,Emily Henkle,Maria Deloria-Knoll,Natalie McCall,Ellen Lee,Orin S. Levine,Rana A. Hajjeh,Kim Mulholland,Thomas Cherian +10 more
TL;DR: Global burden of Hib disease is substantial and almost entirely vaccine preventable, and expanded use of Hib vaccine could reduce childhood pneumonia and meningitis, and decrease child mortality.
Journal ArticleDOI
Hepatitis B and C Virus Infection Among 1.2 Million Persons With Access to Care: Factors Associated With Testing and Infection Prevalence
Philip R. Spradling,Loralee B Rupp,Anne C. Moorman,Mei Lu,Eyasu H. Teshale,Stuart C. Gordon,Cynthia Nakasato,Joseph A. Boscarino,Emily Henkle,David R. Nerenz,Maxine M. Denniston,Scott D. Holmberg +11 more
TL;DR: Even in this population with access to care and lengthy follow-up, only a fraction of expected viral hepatitis infections were identified, which has implications for the identification and care of 4-5 million US residents with HBV and HCV infection.
Journal ArticleDOI
Baseline Characteristics and Mortality Among People in Care for Chronic Viral Hepatitis: The Chronic Hepatitis Cohort Study
Anne C. Moorman,Stuart C. Gordon,Loralee B Rupp,Philip R. Spradling,Eyasu H. Teshale,Mei Lu,David R. Nerenz,Cynthia Nakasato,Joseph A. Boscarino,Emily Henkle,Nancy Oja-Tebbe,Jian Xing,John W. Ward,Scott D. Holmberg +13 more
TL;DR: Baseline demographic, hospitalization, and mortality data from CHeCS highlight the substantial US health burden from chronic viral hepatitis, particularly among persons born during 1945-1964.
Journal ArticleDOI
Noninvasive Serum Fibrosis Markers for Screening and Staging Chronic Hepatitis C Virus Patients in a Large US Cohort
Scott D. Holmberg,Mei Lu,Loralee B Rupp,Lois Lamerato,Anne C. Moorman,Vinutha Vijayadeva,Joseph A. Boscarino,Emily Henkle,Stuart C. Gordon +8 more
TL;DR: In a large observational cohort, FIB-4 was good at differentiating 5 stages of chronic HCV infection and can be useful in screening patients who need biopsy and therapy, for monitoring patients with less advanced disease, and for longitudinal studies.